atezolizumab
Roche
['rcc,(-irccs),(-srcc),(-urcc)', 'atezo']
here we go - adjuvant #rcc data #esmo22. (1) adjuvant atezolizumab x 1 year
dfs 0.93 m1 ned &gt; 12 mos: 14%
t2/t3a: 65% 
Medical Oncologist, @HamHealthSci | Assistant Professor, @McMasterU | Former Fellow, @DanaFarber | Academic focus: genitourinary & rare cancers | Views my own.